383P An exosome-based liquid biopsy assay for predicting therapeutic outcomes in patients with metastatic colorectal cancer treated with anti-EGFR therapy: Results from prospective, first-line, PULSE and POSIBA trials.

Authors :: Goel, A.
Xu, C.
Roy, S.
Esposito, F.M.
Helena, O.
Alonso, V.
Yubero Esteban, A.
Carlos, F-M.
Salud Salvia, M.A.
Gallego Plazas, J.
Rodriguez Monwbray, J.R.
Marta, M.M-R.
Fernandez, J.
Manzano, H.
Aparicio, J.
Feliu, J.
Maurel, J.
Source :: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS711-S712. 2p.
Publication Year :: 2022

Subjects :: *METASTASIS
*COLORECTAL cancer
*TREATMENT effectiveness
*BIOPSY
*LIQUIDS

Full Text Access

Tools